Results 111 to 120 of about 31,907 (263)

Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines

Expert Review of Vaccines, 2017
Introduction: Typhoid and paratyphoid fever remain a global health problem, which – in non-endemic countries – are mainly seen in travelers, particularly in VFRs (visiting friends and relatives), with occasional local outbreaks occurring.
Jane N Zuckerman, Christoph Hatz, Anu Kantele   +2 more
doaj   +1 more source

Quantification of polysaccharide Vi in the typhoid vaccine VaxTyViTM by sandwich ELISA using a monoclonal antibody. [PDF]

, 2016
Elizabeth González Aznar
openalex   +1 more source

The importance of generating evidence on typhoid fever for implementing vaccination strategies

Journal of Infection in Developing Countries, 2008
Typhoid fever, caused by Salmonella enterica serovar Typhi (S. Typhi), remains a major cause of enteric disease and a significant public health problem, predominantly in children in developing countries. Global estimates of typhoid fever range from 17 to
Duncan Steele
doaj  

An observer-blinded, cluster randomised trial of a typhoid conjugate vaccine in an urban South Indian cohort [PDF]

, 2023
Nikhil Sahai, Dilesh Kumar Arunachalam, Tim P. Morris, Andrew Copas, Prasanna Samuel, Venkata Raghava Mohan, Vinod Joseph Abraham, Joshua Anish Selwyn, Praveen Kumar, Winsley Rose, Balaji Veeraraghavan, Gagandeep Kang, Jacob John   +12 more
openalex   +1 more source

Comparison of safety and immunogenicity of a Vi polysaccharide typhoid vaccine with a whole-cell killed vaccine in Malaysian Air Force recruits

Bulletin of the World Health Organization, 2001
OBJECTIVE: To carry out a comparative study of the safety and immunogenicity of Vi polysaccharide vaccine against whole-cell killed (WCK) typhoid vaccine.
Panchanathan Vijayaretnam, Kumar Senthil, Yeap Wynie, Devi Shamala, Ismail Raman, Sarijan Samiran, Sam Salleh Mohd, Jusoh Zahari, Nordin Salleh, Leboulleux Didier, Pang Tikki   +10 more
doaj  

A Phase II, Randomized, Double-blind, Controlled Safety and Immunogenicity Trial of Typhoid Conjugate Vaccine in Children Under 2 Years of Age in Ouagadougou, Burkina Faso: A Methods Paper [PDF]

, 2019
Matthew B. Laurens, Sodiomon B. Sirima, Elizabeth Rotrosen, Mohamadou Siribié, Alfred B. Tiono, Alphonse Ouédraogo, Yuanyuan Liang, Leslie P Jamka, Karen L. Kotloff, Kathleen M. Neuzil   +9 more
openalex   +1 more source

Optimized Detoxification of a Live Attenuated Vaccine Strain (SG9R) to Improve Vaccine Strategy against Fowl Typhoid [PDF]

, 2021
Namhyung Kim, Dae-Sung Ko, Eun-Jin Ha, Sun-Min Ahn, Kang-Seuk Choi, Hyuk‐Joon Kwon   +5 more
openalex   +1 more source

A phase II clinical trial of a Vi-DT typhoid conjugate vaccine in healthy Indonesian adolescents and adults: one-month evaluation of safety and immunogenicity

Tropical Diseases, Travel Medicine and Vaccines
Background Typhoid fever is commonly found until today, especially in developing countries. It has fatal complications and measures must be taken to reduce the incidence of typhoid. Vaccinations are a key factor in prevention.
Sukamto Koesnoe, Bernie Endyarni Medise, Iris Rengganis, Sri Rezeki Hadinegoro, Mita Puspita, Rini Mulia Sari, Jae Seung Yang, Sushant Sahastrabuddhe, Soedjatmiko, Hartono Gunardi, Rini Sekartini, Angga Wirahmadi, Aria Kekalih, Sreshta Mukhi, Hindra Irawan Satari, Novilia Sjafri Bachtiar   +15 more
doaj   +1 more source

Reactions Among Infants Immunized Intramuscularly with Typhoid Vaccine in Adjuvant [PDF]

, 1966
John Snyder, Samuel D. Bell, Edward S. Murray, Roger Nichols   +3 more
openalex   +1 more source

Typhoid conjugate vaccines for preventing typhoid fever (enteric fever) [PDF]

, 2023
Natasha R Gloeck, Trudy Leong, Chinwe Juliana Iwu, Patrick DMC Katoto, Tamara Kredo, Charles Shey Wiysonge   +5 more
openalex   +1 more source